100% triage.
Munro also explained very well the possibilities with the many therapeutic programs we have in progress.
Looking forward to the Ginko updates this quarter.
Also we have additional distribution partners to be announced this quarter. Revenues from microbiome testing services will start to ramp up this quarter.
Microba will prove to be a long term compounder imo.
- Forums
- ASX - By Stock
- Ann: Q2 FY23 Quarterly Investor Presentation
MAP
microba life sciences limited
Add to My Watchlist
4.17%
!
9.2¢

100% triage.Munro also explained very well the possibilities...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
-0.004(4.17%) |
Mkt cap ! $47.38M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.2¢ | $11.09K | 118.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 20774 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 114482 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 20774 | 0.092 |
4 | 60967 | 0.091 |
7 | 405677 | 0.090 |
2 | 192844 | 0.089 |
2 | 12552 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 114482 | 1 |
0.099 | 88000 | 1 |
0.100 | 100000 | 1 |
0.105 | 103000 | 1 |
0.110 | 1714 | 1 |
Last trade - 15.11pm 29/07/2025 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |